This profile follows BLI – Banque de Luxembourg Investments’s institutional portfolio moves as disclosed in its SEC Form 13F filings, updated every quarter as new data becomes available. Rather than a one-off snapshot, this page is meant to serve as a running record of the fund’s buying and selling activity over time, giving a sense of how its holdings evolve from one quarter to the next.
Form 13F filings report a quarterly snapshot of long U.S. equity positions rather than exact trade dates, so moves below are described as occurring during the quarter rather than on any specific day. This entry covers the quarter ending 2026-03-31.
Quarter ending 2026-03-31: new positions and exits
The most notable move this quarter was a new position in AstraZeneca PLC (AZN), which BLI – Banque de Luxembourg Investments opened at a value of roughly $68.99 million. This represents the largest single change in the portfolio for the period and stands out as the fund’s clearest addition of the quarter.
On the exit side, the fund closed out several positions entirely. It fully exited Zoetis Inc Class A, a holding previously worth about $41.56 million, along with Zebra Technologies Corporation Class A, valued at roughly $15.76 million before the exit. Xylem Inc was also removed from the portfolio, with the prior position worth approximately $12.39 million, as was Yum China Holdings Inc, previously valued near $9.49 million. Together these exits point to a broader trimming of exposure across a mix of healthcare, industrial, and consumer names during the period.
Position trimmed: Applied Materials
Beyond the full exits, BLI – Banque de Luxembourg Investments also reduced its stake in Applied Materials Inc by about 15%, taking the position from roughly $22.55 million down to approximately $19.20 million. This partial reduction is a smaller-scale adjustment compared to the outright exits above, but it fits the same general pattern of paring back rather than adding to existing technology holdings this quarter.
Taken together, this quarter’s filing shows one new position opened, four positions closed out entirely, and one existing holding reduced, with no other changes reported. As with any 13F-based tracker, this data reflects long U.S. equity positions only and excludes short positions, options, and non-U.S. listed securities that may also be part of the fund’s broader strategy. Future quarterly filings will be added to this page as they become available, building out a longer-term view of how BLI – Banque de Luxembourg Investments positions its portfolio across market cycles. This content is provided for informational and tracking purposes only and should not be read as a recommendation to buy or sell any of the securities mentioned.
Related ticker coverage
Source: SEC Form 13F filings. This page updates every quarter.